Bristol-Myers Squibb Company Ce
Bristol-Myers Squibb Company Ce (CELG-RI) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CELG-RI · as of Jun 8, 2026
Key Statistics
Explore Bristol-Myers Squibb Company Ce Data
celg-ri stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
celg-ri competitorsCELG-RI
AMGN
CVS
GILD
GSK
HCAStock Performance
Full HistoryAbout Bristol-Myers Squibb Company Ce
Bristol-Myers Squibb Company Ce Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced fr…
what is bristol-myers squibb company ce · celg-ri stock overview · bristol-myers squibb company ce company profile · who is bristol-myers squibb company ce ceo · celg-ri NYSE · bristol-myers squibb company ce headquarters · bristol-myers squibb company ce business segments
About Stock Overview & Key Data
Bristol-Myers Squibb Company Ce (CELG-RI) is a Healthcare company in the Drug Manufacturers - General industry, listed on NYSE since Nov 21, 2019. As of the latest trading session, CELG-RI stock price is $0.10, with a market capitalization of $203.6M. The stock has returned +287.94% over the past 12 months and +38.66% year-to-date.
In fiscal year 2018, Bristol-Myers Squibb Company Ce reported revenue of $15.3B. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Bristol-Myers Squibb Company Ce (CELG-RI) stock price is $0.10. The stock is traded on NYSE under the ticker symbol CELG-RI. The 52-week range is $0.10 – $0.12.